Biophex
NDC Package 45737-606-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Biophex is UsesTemporarily relieves these symptoms associated with a cough, the common cold, hay fever, or other upper respiratory allergieshelps loosen phlegm (mucus)loosens nasal congestionsthin bronchial secretionsdrain bronchial tubesmake coughs more productiveclears stuffy noseclear nasal passagewaysshrinks swollen membranes. Marketed by Advanced Generic Corporation, this product is identified by NDC 45737-606 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
45737-606-10
Package Description
100 TABLET in 1 BOTTLE
Product Code
45737-606
11-Digit Billing Format
45737060610
RxNorm Crosswalk
  • RxCUI: 1946782 - guaiFENesin 388 MG / phenylephrine HCl 10 MG Oral Tablet
  • RxCUI: 1946782 - guaifenesin 388 MG / phenylephrine hydrochloride 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Biophex TR
Dosage Form
-
Usage Information
UsesTemporarily relieves these symptoms associated with a cough, the common cold, hay fever, or other upper respiratory allergieshelps loosen phlegm (mucus)loosens nasal congestionsthin bronchial secretionsdrain bronchial tubesmake coughs more productiveclears stuffy noseclear nasal passagewaysshrinks swollen membranes

Regulatory & Marketing

Labeler Name
Advanced Generic Corporation
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
04-01-2014
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45737-606-10 identifies a specific commercial package of 100 tablet in 1 bottle of Biophex TR, labeled by Advanced Generic Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Advanced Generic Corporation on April 01, 2014. The current certification is valid through December 31, 2017.

How is this Advanced Generic Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45737060610. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45737-606-10
11-Digit CMS (5-4-2)
45737-0606-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.